Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: J Thromb Haemost. 2012 Apr;10(4):719–722. doi: 10.1111/j.1538-7836.2012.04665.x

Table 1.

Associations between F3 rs12029080 G-allele and incident venous thrombosis

Design Events,
n
Male,
%
Age*,
yrs
PE,
%
Idiopathic,
%
MAF Beta coefficient
(SE)
Odd ratio (95% CI)
HVH CC 656 0 64.7 48 59 0.304 −0.073 (0.092) 0.93 (0.8, 1.08)
EOVT CC 419 55 36.0 0 100 0.327 0.091 (0.089) 1.10 (0.95, 1.27)
LITE (ARIC) Cohort 248 47 56.0 42 36 0.299 0.040 (0.097) 1.04 (0.89, 1.22)
LITE (CHS) Cohort 119 43 73.0 30 39 0.317 0.199 (0.138) 1.22 (0.97, 1.53)
MARTHA CC 1542 34 47.0 22 55 0.316 0.023 (0.060) 1.02 (0.93, 1.13)
Mayo VTE CC 1503 50 54.9 50 43 0.299 −0.068 (0.063) 0.93 (0.84, 1.04)
RS-1 Cohort 177 43 69.5 44 53 0.291 −0.108 (0.120) 0.90 (0.74, 1.09)
RS-2 Cohort 19 63 66.3 42 53 0.286 0.161 (0.353) 1.17 (0.66, 2.10)
WGHS Cohort 434 0 65.4 41 44 0.299 0.173 (0.076) 1.19 (1.05, 1.35)

Combined 5117 34 54.1 35 53 0.299** 0.026 (0.029)*** 1.03 (0.89-1.08)

CI = confidence interval; MAF = minor allele frequency; SE = standard error. The Rotterdam Study analyzed 2 subcohorts separately: RS-1 and RS-2.

*

Age at the time of the event among case subjects.

**

Averaged.

***

Weighted by inverse of variance.